×
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
NYSE:BBLN

Babylon Stock Forecast, Price & News

$1.08
-0.08 (-6.90%)
(As of 06/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.05
$1.16
50-Day Range
$0.96
$3.72
52-Week Range
$0.95
$16.00
Volume
10.65 million shs
Average Volume
745,755 shs
Market Capitalization
$46.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
30 days | 90 days | 365 days | Advanced Chart

Receive BBLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Babylon and its competitors with MarketBeat's FREE daily newsletter.

BBLN Stock Forecast (MarketRank)

Overall MarketRank

1.19 out of 5 stars

Medical Sector

1188th out of 1,418 stocks

Health Services Industry

12th out of 18 stocks

Analyst Opinion: 3.2Community Rank: 1.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
Babylon logo

About Babylon (NYSE:BBLN)

Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally. The company was founded in 2013 and is headquartered in London, the United Kingdom.

BBLN Stock News Headlines

Babylon Set to Join Russell 3000® Index
See More Headlines

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
2,573
Year Founded
N/A

Company Calendar

Last Earnings
5/12/2022
Today
6/24/2022
Next Earnings (Estimated)
8/11/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$6.00
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+455.6%
Consensus Rating
Hold
Rating Score (0-4)
2.42857142857143
Research Coverage
7 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$322.92 million
Book Value
$3.83 per share

Miscellaneous

Free Float
N/A
Market Cap
$46.58 million
Optionable
Not Optionable
Beta
1.21














Babylon Frequently Asked Questions

Should I buy or sell Babylon stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Babylon in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Babylon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BBLN, but not buy additional shares or sell existing shares.
View analyst ratings for Babylon
or view top-rated stocks.

What is Babylon's stock price forecast for 2022?

7 Wall Street analysts have issued 12 month price objectives for Babylon's shares. Their BBLN stock forecasts range from $1.50 to $10.00. On average, they predict Babylon's stock price to reach $6.00 in the next year. This suggests a possible upside of 455.6% from the stock's current price.
View analysts' price targets for Babylon
or view top-rated stocks among Wall Street analysts.

How has Babylon's stock price performed in 2022?

Babylon's stock was trading at $5.83 at the beginning of 2022. Since then, BBLN stock has decreased by 81.5% and is now trading at $1.08.
View the best growth stocks for 2022 here
.

Are investors shorting Babylon?

Babylon saw a increase in short interest in May. As of May 31st, there was short interest totaling 1,140,000 shares, an increase of 119.9% from the May 15th total of 518,300 shares. Based on an average daily trading volume, of 961,500 shares, the days-to-cover ratio is presently 1.2 days. Currently, 1.2% of the company's stock are sold short.
View Babylon's Short Interest
.

When is Babylon's next earnings date?

Babylon is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Babylon
.

How were Babylon's earnings last quarter?

Babylon Holdings Limited (NYSE:BBLN) released its quarterly earnings data on Thursday, May, 12th. The company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.23) by $0.01. The company had revenue of $266.45 million for the quarter, compared to analysts' expectations of $238.49 million.
View Babylon's earnings history
.

What guidance has Babylon issued on next quarter's earnings?

Babylon issued an update on its FY 2022 earnings guidance on Thursday, June, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.00B-, compared to the consensus revenue estimate of $966.89 million.

Who are Babylon's key executives?

Babylon's management team includes the following people:
  • Dr. Ali Parsadoust, Founder, Chairman & CEO (Age 56)
  • Mr. Charlie Steel, Chief Financial Officer (Age 37)
  • Mr. Steve Davis, Chief Technology Officer (Age 55)
  • Ms. Stina Sanders, Communications Mang.
  • Ms. Samira Lowman, Chief People Officer
  • Mr. Darshak Sanghavi M.D., Global Chief Medical Officer (Age 51)
  • Mr. Paul-Henri Ferrand, Chief Bus. Officer (Age 58)
  • Mr. Yon Nuta, Chief Product Officer (Age 41)
  • Ms. Mairi Johnson, Chief Partnerships Officer & Employee Director (Age 55)

What is Babylon's stock symbol?

Babylon trades on the New York Stock Exchange (NYSE) under the ticker symbol "BBLN."

Who are Babylon's major shareholders?

Babylon's stock is owned by many different retail and institutional investors. Top institutional investors include Qube Research & Technologies Ltd (0.79%), Nicholas Investment Partners LP (0.23%), Goldman Sachs Group Inc. (0.11%) and Renaissance Technologies LLC (0.10%).

Which major investors are buying Babylon stock?

BBLN stock was acquired by a variety of institutional investors in the last quarter, including Nicholas Investment Partners LP, Qube Research & Technologies Ltd, Renaissance Technologies LLC, and Goldman Sachs Group Inc..

How do I buy shares of Babylon?

Shares of BBLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Babylon's stock price today?

One share of BBLN stock can currently be purchased for approximately $1.08.

How much money does Babylon make?

Babylon (NYSE:BBLN) has a market capitalization of $46.58 million and generates $322.92 million in revenue each year.

How many employees does Babylon have?

Babylon employs 2,573 workers across the globe.

How can I contact Babylon?

The official website for Babylon is www.babylonhealth.com. The company can be reached via phone at 44 20 7100 0762 or via email at [email protected].

This page (NYSE:BBLN) was last updated on 6/24/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.